Penn Davis Mcfarland Inc Amgen Inc Transaction History

Penn Davis Mcfarland Inc

$953 Million
Q3 2025

A detailed history of Penn Davis Mcfarland Inc transactions in Amgen Inc stock. As of the latest transaction made, Penn Davis Mcfarland Inc holds 18,831 shares of AMGN stock, worth $5.5 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

18,831

Previous 18,831 -0.0%

Holding current value

$5.5 Million

Previous $5.26 Million 1.08%

% of portfolio

0.56%

Previous 0.6%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$262.28 - $309.85 $32,785 - $38,731	-125 Reduced 0.66%	18,831 $5.26 Million
Q1 2025 Apr 23, 2025	SELL	$258.59 - $327.36 $18,618 - $23,569	-72 Reduced 0.38%	18,956 $5.91 Million
Q4 2024 Jan 16, 2025	SELL	$258.78 - $328.31 $31,571 - $40,053	-122 Reduced 0.64%	19,028 $4.96 Million
Q3 2024 Oct 18, 2024	BUY	$309.38 - $337.38 $5.46 Million - $5.95 Million	17,650 Added 1176.67%	19,150 $6.17 Million
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $7,787 - $9,894	-34 Reduced 2.22%	1,500 $394,000
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $1,571 - $1,772	-7 Reduced 0.45%	1,534 $346,000
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $1,614 - $1,797	7 Added 0.46%	1,541 $375,000
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $6,657 - $7,758	-30 Reduced 1.92%	1,534 $382,000
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $12,109 - $15,564	64 Added 4.27%	1,564 $377,000
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $250,935 - $286,500	1,500	1,500 $280,000

Others Institutions Holding AMGN

# of Institutions

3,285

Shares Held

440M

Call Options Held

6.25M

Put Options Held

7.38M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Davis Mcfarland Inc, based on Form 13F filings with the SEC.

News

Stay updated on Penn Davis Mcfarland Inc with notifications on news.

Account

Penn Davis Mcfarland Inc Amgen Inc Transaction History